Hypoxia-inducible Factor 1α and Antiangiogenic Activity of Farnesyltransferase Inhibitor SCH66336 in Human Aerodigestive Tract Cancer
Ji‐Youn Han(The University of Texas MD Anderson Cancer Center), Ho‐Young Lee(Seoul National University of Science and Technology)
Cited by 97
Related Papers
Molecular targeted therapy for anticancer treatment
|Experimental & Molecular Medicine|2022|495
Heterodimerization of Insulin-like Growth Factor Receptor/Epidermal Growth Factor Receptor and Induction of Survivin Expression Counteract the Antitumor Action of Erlotinib
|Cancer Research|2006|336
Association of PD-L1 Expression with Tumor-Infiltrating Immune Cells and Mutation Burden in High-Grade Neuroendocrine Carcinoma of the Lung
|Journal of Thoracic Oncology|2018|82
Effects of Insulin-like Growth Factor Binding Protein-3 and Farnesyltransferase Inhibitor SCH66336 on Akt Expression and Apoptosis in Non-Small-Cell Lung Cancer Cells
|JNCI Journal of the National Cancer Institute|2004|74